66.85  0.34 (0.51%)		06-12 16:00
Open: 66.68 High: 67.03 Volume: 1,161,190		Pre. Close: 66.51 Low: 66.1 Market Cap: 32,583(M)

Short term
Mid term
Targets	6-month :	79.98	1-year :	93.42
Resists	First :	68.48	Second :	79.98
Pivot price	66.32
Supports	First :	64.37	Second :	61.83
MAs	MA(5) :	66.69	MA(20) :	66.29
	MA(100) :	74.91	MA(250) :	78.1
MACD	MACD :	-0.9	Signal :	-1.4
%K %D	K(14,3) :	55.4	D(3) :	59.7
RSI	RSI(14): 47.8
52-week	High :	92.09	Low :	61.83

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ALC ] has closed below upper band by 37.5%. Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	67.12 - 67.39	67.39 - 67.65
Low:	65.42 - 65.72	65.72 - 66.01
Close:	66.37 - 66.84	66.84 - 67.29

Alcon Inc. is a global leader in eye care, engaging in the comprehensive lifecycle of ophthalmic solutions, from initial research and development to manufacturing, distribution, and worldwide sales. Its diverse portfolio serves both eye care professionals and the patients they treat across the globe. The company's operations are divided into two main segments: 1. Surgical Segment: This division provides a vast array of products crucial for ophthalmic surgical procedures. Offerings encompass advanced equipment, sophisticated diagnostic tools, and implantable devices such as intraocular lenses (IOLs). It also supplies essential consumables, including viscoelastics, specialized surgical solutions, incisional instruments, and custom surgical procedure packs. Key product areas within this segment feature: Cataract Management: Technologies like the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and the ORA system for intra-operative measurements, along with custom pak surgical procedure kits. Vitreoretinal Interventions: Including Constellation Vision Systems, procedure packs, lasers, hand-held microsurgical instruments (such as grieshaber and MIVS), a range of scissors, forceps, micro-instruments, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive Correction: WaveLight lasers and Contoura Vision, specifically utilized for LASIK treatments. Glaucoma Solutions: The EX-PRESS glaucoma filtration device. Advanced Implantables: Such as AcrySof IQ IOLs, which include both monofocal IOLs and cutting-edge technology IOLs marketed under the PanOptix and ReSTOR brands, designed to correct presbyopia and astigmatism during cataract surgery. 2. Vision Care Segment: This segment delivers products aimed at daily vision needs and overall ocular health. Its offerings include daily disposable, reusable, and color-enhancing contact lenses. Furthermore, it provides a variety of eye health products addressing issues like dry eye, glaucoma, contact lens maintenance, and ocular allergies, alongside eye vitamins and redness relievers. These are available under prominent brands such as TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Established in 1945, Alcon Inc. changed its name from Alcon Universal S.A. to its current designation in December 2001. The company's corporate headquarters are located in Geneva, Switzerland.

Thu, 04 Jun 2026
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued - GuruFocus

Mon, 01 Jun 2026
Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector - DirectorsTalk Interviews

Sun, 31 May 2026
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy) (NYSE:ALC) - Seeking Alpha

Thu, 28 May 2026
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - TradingView

Mon, 25 May 2026
Alcon Inc. (ALC) Stock Analysis: Eyeing A 29.63% Potential Upside - DirectorsTalk Interviews

Fri, 15 May 2026
Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	488 (M)
Shares Float	486 (M)
Held by Insiders	0.1 (%)
Held by Institutions	66.1 (%)
Shares Short	5,370 (K)
Shares Short P.Month	5,150 (K)

EPS	1.66
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	45.38
Profit Margin	7.6 %
Operating Margin	10.7 %
Return on Assets (ttm)	2.4 %
Return on Equity (ttm)	3.7 %
Qtrly Rev. Growth	9.3 %
Gross Profit (p.s.)	12.15
Sales Per Share	21.79
EBITDA (p.s.)	4.63
Qtrly Earnings Growth	-44.6 %
Operating Cash Flow	2,300 (M)
Levered Free Cash Flow	1,190 (M)

PE Ratio	40.02
PEG Ratio	1.4
Price to Book value	1.47
Price to Sales	3.06
Price to Cash Flow	14.17

Dividend	0.36
Forward Dividend	0
Dividend Yield	0.5%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.